SIRION Biotech Achieves ISO-9001:2015 Certification
SIRION Biotech GmbH is proud to announce our achievement of ISO 9001:2015 certification by DEKRA. ISO 9001 is the world…
SIRION Biotech GmbH is proud to announce our achievement of ISO 9001:2015 certification by DEKRA. ISO 9001 is the world…
SIRION Biotech, das führende deutsche Unternehmen für Virale Vektoren, präsentiert am 17. November 2021 ab 14.00 (GMT) e…
SIRION Biotech, the leading German viral vector company, will present a Webinar on November 17 at 2 PM GMT discussing op…
The French Ministry of Higher Education, Research and Innovation have granted SIRION Biotech a 3-year CIR (Crédit Impôt…
SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced…
A recent collaboration between Associate Professor Peter Johannes Holst at University of Copenhagen, his research group…
The viral vector specialist SIRION Biotech GmbH today announces the signing of a preferred partnership agreement with He…
SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene…
With the beginning of a new fiscal year SIRION Biotech GmbH, located at the Innovation and Start-Up Center for Biotechno…
Die im Innovations- und Gründerzentrum für Biotechnologie (IZB) Martinsried ansässige SIRION Biotech GmbH meldet zu Jahr…